DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
- Status
- TERMINATED
- Phase
- PHASE2
A Study of ICP-192 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
- Status
- TERMINATED
- Phase
- N/A
REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Liver Cancer Registry Platform
- Status
- RECRUITING
- Phase
- N/A
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
- Status
- RECRUITING
- Phase
- NA
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Therapy in Biliary Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Hepatobiliary Tumors Tissue Samples Acquisition
- Status
- UNKNOWN
- Phase
- N/A
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
- Status
- UNKNOWN
- Phase
- N/A
Advanced Endoscopy During COVID-19
- Status
- COMPLETED
- Phase
- N/A
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2